1-4 of 4
Ji-Young Byeun
Close
Sort by
Journal Articles

Dynamics and Characteristics of BCR-ABL1 Multiple Mutations in Tyrosine Kinase Inhibitor Resistant CML

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, Ju-Hee Bang, Ji-Young Byeun, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Saengsuree Jootar, Dong-Wook Kim
Journal: Blood
Blood (2012) 120 (21): 1677.
https://doi.org/10.1182/blood.V120.21.1677.1677
Published: 2012
Journal Articles

Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response 4.5 (CMR 4.5 )

Hyun-Gyung Goh, Soo-Young Choi, Ju-Hee Bang, Soo-Hyun Kim, Eun-Jung Jang, Dongho Kim, Ji-Young Byeun, Joon Seong Park, Hyeoung-Joon Kim, Hawk Kim, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2763.
https://doi.org/10.1182/blood.V118.21.2763.2763
Published: 2011
Journal Articles

Efficacy of Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib (RE-NICE Multicenter Study)

Hyun-Gyung Goh, Saengsuree Jootar, Hyeoung-Joon Kim, Sang Kyun Sohn, Joon Seong Park, Sung Hyun Kim, Dae Young Zang, Suk-Joong Oh, Soo-Young Choi, Ju-Hee Bang, Soo-Hyun Kim, Eun-Jung Jang, Sung-Eun Lee, Dongho Kim, Ji-Young Byeun, Richard C. Woodman, Tomasz Szczudlo, Hee Jung Kim, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2765.
https://doi.org/10.1182/blood.V118.21.2765.2765
Published: 2011
Journal Articles

Correlation of Molecular Response At 18 Month with Survival Benefits As Response-Related Prognostic Factor

Soo-Hyun Kim, Dongho Kim, Hyun-Gyung Goh, Soo-Young Choi, Ju-Hee Bang, Ji-Young Byeun, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2766.
https://doi.org/10.1182/blood.V118.21.2766.2766
Published: 2011